The role of autophagy in the cytotoxicity induced by recombinant human arginase in laryngeal squamous cell carcinoma

Verfasser / Beitragende:
[Chen Lin, Ziyu Wang, Li Li, Yong He, Jiajun Fan, Zhongyu Liu, Shuwei Zhao, Dianwen Ju]
Ort, Verlag, Jahr:
2015
Enthalten in:
Applied Microbiology and Biotechnology, 99/20(2015-10-01), 8487-8494
Format:
Artikel (online)
ID: 605499721
LEADER caa a22 4500
001 605499721
003 CHVBK
005 20210128100552.0
007 cr unu---uuuuu
008 210128e20151001xx s 000 0 eng
024 7 0 |a 10.1007/s00253-015-6565-6  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00253-015-6565-6 
245 0 4 |a The role of autophagy in the cytotoxicity induced by recombinant human arginase in laryngeal squamous cell carcinoma  |h [Elektronische Daten]  |c [Chen Lin, Ziyu Wang, Li Li, Yong He, Jiajun Fan, Zhongyu Liu, Shuwei Zhao, Dianwen Ju] 
520 3 |a Laryngeal squamous cell carcinoma (LSCC), one of the most common malignant solid tumors in the world, has a high rate of mortality, recurrence, and metastasis. Recombinant human arginase (rhArg) recently has been developed in arginine deprivation therapy for a number of malignant tumors. In the present study, we observed that rhArg triggered significant cytotoxicity in human laryngeal squamous cell carcinoma Tu212 cells. Meanwhile, we observed that rhArg simultaneously activated autophagic flux in Tu212 cells, which was demonstrated by the accumulation of autophagosome and light chain 3 II (LC3-II). And, we explored the role of autophagy in cytotoxicity induced by rhArg in Tu212 cells. Autophagy inhibitors including chloroquine (CQ) and bafilomycin A1 (Baf A1) enhanced cytotoxicity induced by rhArg, implying the protective role of autophagy in rhArg-treated Tu212 cells. Moreover, Akt/mTOR signaling pathway was most possibly to participate in the rhArg-induced autophagy. Meanwhile, rhArg could upregulate the phosphorylation of ERK1/2 in a time-dependent manner. Therefore, all the results illuminated the cytoprotective role of autophagy in the treatment of rhArg in laryngeal squamous carcinoma Tu212 cells and provided a potential approach for LSCC therapy by rhArg combined with autophagy inhibitors. 
540 |a Springer-Verlag Berlin Heidelberg, 2015 
690 7 |a Autophagy  |2 nationallicence 
690 7 |a Recombinant human arginase  |2 nationallicence 
690 7 |a Laryngeal squamous cell carcinoma  |2 nationallicence 
690 7 |a Cytotoxicity  |2 nationallicence 
700 1 |a Lin  |D Chen  |u Department of Otolaryngology, Changzheng Hospital, Second Military Medical University, 200003, Shanghai, China  |4 aut 
700 1 |a Wang  |D Ziyu  |u Department of Biosynthesis & Key Lab of Smart Drug Delivery of Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China  |4 aut 
700 1 |a Li  |D Li  |u Department of Otolaryngology, Changzheng Hospital, Second Military Medical University, 200003, Shanghai, China  |4 aut 
700 1 |a He  |D Yong  |u Department of Otolaryngology, The Affiliated Hospital of School of Medicine of Ningbo University, Ningbo, Zhejiang Province, China  |4 aut 
700 1 |a Fan  |D Jiajun  |u Department of Biosynthesis & Key Lab of Smart Drug Delivery of Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China  |4 aut 
700 1 |a Liu  |D Zhongyu  |u Department of Otolaryngology, Changzheng Hospital, Second Military Medical University, 200003, Shanghai, China  |4 aut 
700 1 |a Zhao  |D Shuwei  |u Department of Otolaryngology, Changzheng Hospital, Second Military Medical University, 200003, Shanghai, China  |4 aut 
700 1 |a Ju  |D Dianwen  |u Department of Biosynthesis & Key Lab of Smart Drug Delivery of Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China  |4 aut 
773 0 |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/20(2015-10-01), 8487-8494  |x 0175-7598  |q 99:20<8487  |1 2015  |2 99  |o 253 
856 4 0 |u https://doi.org/10.1007/s00253-015-6565-6  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00253-015-6565-6  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Lin  |D Chen  |u Department of Otolaryngology, Changzheng Hospital, Second Military Medical University, 200003, Shanghai, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Wang  |D Ziyu  |u Department of Biosynthesis & Key Lab of Smart Drug Delivery of Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Li  |D Li  |u Department of Otolaryngology, Changzheng Hospital, Second Military Medical University, 200003, Shanghai, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a He  |D Yong  |u Department of Otolaryngology, The Affiliated Hospital of School of Medicine of Ningbo University, Ningbo, Zhejiang Province, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Fan  |D Jiajun  |u Department of Biosynthesis & Key Lab of Smart Drug Delivery of Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Liu  |D Zhongyu  |u Department of Otolaryngology, Changzheng Hospital, Second Military Medical University, 200003, Shanghai, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Zhao  |D Shuwei  |u Department of Otolaryngology, Changzheng Hospital, Second Military Medical University, 200003, Shanghai, China  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ju  |D Dianwen  |u Department of Biosynthesis & Key Lab of Smart Drug Delivery of Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Applied Microbiology and Biotechnology  |d Springer Berlin Heidelberg  |g 99/20(2015-10-01), 8487-8494  |x 0175-7598  |q 99:20<8487  |1 2015  |2 99  |o 253